Covered recipient · General Payments record
REBECCA ASHBURN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2025
$3,494.87
- Reported across 158 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,063.94 | 52 |
| Education | $99.99 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $189.04 | 6 |
| ABBVIE INC. | $135.08 | 8 |
| Syndax Pharmaceuticals, Inc. | $69.55 | 3 |
| SOBI, INC | $67.43 | 3 |
| Incyte Corporation | $63.70 | 3 |
| GENZYME CORPORATION | $63.50 | 3 |
| Janssen Biotech, Inc. | $56.92 | 3 |
| Celgene Corporation | $54.07 | 2 |
| SANOFI-AVENTIS U.S. LLC | $43.45 | 2 |
| Regeneron Healthcare Solutions, Inc. | $40.57 | 2 |
| Azurity Pharmaceuticals, Inc. | $36.28 | 2 |
| PFIZER INC. | $32.43 | 2 |
| JAZZ PHARMACEUTICALS INC. | $28.02 | 1 |
| Geron Corporation | $27.48 | 1 |
| Merck Sharp & Dohme Corporation | $26.71 | 1 |
| Ipsen Biopharmaceuticals, Inc | $25.29 | 1 |
| Daiichi Sankyo Inc. | $25.07 | 1 |
| Genentech USA, Inc. | $23.18 | 1 |
| Karyopharm Therapeutics Inc. | $22.16 | 1 |
| Blueprint Medicines Corporation | $21.48 | 1 |
| BeOne Medicines USA, Inc. | $21.08 | 1 |
| KYOWA KIRIN, INC. | $20.79 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.24 | 1 |
| GlaxoSmithKline, LLC. | $19.17 | 1 |
| Lilly USA, LLC | $17.73 | 1 |
| Stemline Therapeutics Inc. | $14.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (53)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.